GHRL and peripheral arterial disease: Exogenous ghrelin has been shown to have an angiogenic potential in vitro8,9 and in vivo10–12, whilst also protecting against apoptosis13 and inflammation14, all of which are highly desirable mechanisms for the treatment of PAD.